Keyphrases
Allosteric Inhibitor
100%
Muscarinic Acetylcholine Receptor
100%
Amyloidogenic Processing
100%
Antipsychotic Activity
100%
M1 muscarinic Acetylcholine Receptor
100%
Adverse Effects
66%
Alzheimer's Disease
66%
Schizophrenia Symptoms
66%
Binding Site
33%
Amyloid Precursor Protein
33%
Clinical Data
33%
Allosteric Site
33%
Patch-clamp Recording
33%
Predictive Models
33%
Mutagenesis
33%
Muscarinic Agonists
33%
Highly Selective
33%
Acetylcholine
33%
Subtype Selectivity
33%
Agonist Activity
33%
Imidazole
33%
Excitatory Synaptic Transmission
33%
Clinical Development
33%
Pyramidal Neurons
33%
Molecular Pharmacology
33%
Inhibitory Synaptic Transmission
33%
Benzo
33%
Psychotic Symptoms
33%
Catalepsy
33%
Selective Activation
33%
Selective Agonist
33%
Subtype Specificity
33%
Orthosteric
33%
Pharmacology Studies
33%
M4 muscarinic Acetylcholine Receptor
33%
Specificity Effects
33%
Transmission Response
33%
M1 Receptor
33%
NMDA Receptor Current
33%
Selective Activator
33%
Non-amyloidogenic Pathway
33%
Neuroscience
Agonist
100%
Amyloid Protein
100%
Muscarinic Acetylcholine Receptor M1
100%
Antipsychotic
100%
Adverse Effect
66%
Alzheimer's Disease
66%
In Vitro
33%
Patch Clamp Technique
33%
Amyloid Precursor Protein
33%
Binding Site
33%
Pyramidal Cell
33%
Acetylcholine
33%
Synaptic Transmission
33%
NMDA Receptor
33%
Molecular Pharmacology
33%
Allosteric Site
33%
Muscarinic Acetylcholine Receptor M4
33%
Muscarinic Agonist
33%
Catalepsy
33%
Receptor
33%
Mutagenesis
33%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Antipsychotic
100%
Amyloid Protein
100%
Muscarinic Receptor
100%
Receptor
50%
Amyloid Precursor Protein
50%
Binding Site
50%
Muscarinic Agent
50%
Acetylcholine
50%
Mutagenesis
50%
N Methyl Dextro Aspartic Acid Receptor
50%
Catalepsy
50%
Molecular Pharmacology
50%